DOI:
10.1055/s-00000019
Fortschritte der Neurologie · Psychiatrie
LinksClose Window
References
Fenton WS, Dickerson F, Boronow J et al.
A placebo-controlled trial of omega-3 fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and cognitive impairment in schizophrenia.
Am J Psychiatry 2001;
158: 2071-2074
We do not assume any responsibility for the contents of the web pages of other providers.